Lista de obras - Kengo Azushima - Dominio Público Uruguay

ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in Mice.

artículo científico publicado en 2017

Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.

artículo científico publicado en 2013

Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.

artículo científico publicado en 2013

Adipocyte-Specific Enhancement of Angiotensin II Type 1 Receptor-Associated Protein Ameliorates Diet-Induced Visceral Obesity and Insulin Resistance

artículo científico publicado en 2017

Aliskiren induced remarkable hypertriglyceridemia

artículo científico publicado en 2012

An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities.

artículo científico publicado en 2017

An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model

artículo científico publicado en 2017

Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology

artículo científico publicado en 2015

Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.

artículo científico publicado en 2017

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue

artículo científico publicado en 2018

Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line

scientific article published on 12 November 2019

Angiotensin receptor-binding molecule in leukocytes in association with the systemic and leukocyte inflammatory profile

artículo científico publicado en 2018

Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity

artículo científico publicado en 2013

Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity

artículo científico publicado en 2013

Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes

scientific article published on 28 January 2016

Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY)

scientific article published on 09 May 2012

Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease

artículo científico publicado en 2016

Day-by-day home-measured blood pressure variability: another important factor in hypertension with diabetic nephropathy?

artículo científico publicado en 2011

Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension

artículo científico publicado en 2014

Dual inhibitory action on aldosterone by combined angiotensin receptor antagonism and neprilysin inhibition

artículo científico publicado en 2016

Early Enhanced Leucine-Rich -2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice

scientific article published on 01 November 2018

Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases.

artículo científico publicado en 2016

Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension

artículo científico publicado en 2019

Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders

artículo científico publicado en 2014

Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice

artículo científico publicado en 2020

Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients

artículo científico publicado en 2012

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia

artículo científico publicado en 2015

Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice

artículo científico publicado en 2019

Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.

artículo científico publicado en 2014

Effects of the Angiotensin receptor blocker olmesartan on adipocyte hypertrophy and function in mice with metabolic disorders.

artículo científico publicado en 2014

Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease ⬇️

artículo científico publicado el 8 de septiembre de 2011

Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension

artículo científico publicado en 2013

Enhancement of intrarenal plasma membrane calcium pump isoform 1 expression in chronic angiotensin II-infused mice

artículo científico publicado en 2017

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice

artículo científico publicado en 2017

Fetal programming by high-sucrose diet during pregnancy affects the vascular angiotensin II receptor-PKC-L-type Ca(2+) channels (Cav1.2) axis to enhance pressor responses

artículo científico publicado en 2014

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabe

artículo científico publicado en 2019

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy

scientific article published on 31 July 2018

Involvement of Runx3 in the basal transcriptional activation of the mouse angiotensin II type 1 receptor-associated protein gene.

artículo científico publicado en 2011

L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.

artículo científico publicado en 2013

Mass clinical survey as a possible population strategy for the better control of hypertension in Japan

artículo científico publicado en 2020

Modelling diabetic nephropathy in mice.

artículo científico publicado en 2017

Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis

scientific article published on 07 September 2019

Possible impact of electronegative LDL on atherosclerosis in type 2 diabetes

artículo científico publicado en 2017

Possible interesting link between Janus kinase 2 mutation and renovascular hypertension.

artículo científico publicado en 2018

Possible therapeutic impact of the iron chelation on renal fibrosis

artículo científico publicado en 2015

Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension.

artículo científico publicado en 2016

Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors

artículo científico publicado en 2020

Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease

artículo científico publicado en 2012

Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation

artículo científico publicado en 2015

Rituximab treatment for adult purpura nephritis with nephrotic syndrome.

artículo científico publicado en 2013

The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

artículo científico publicado en 2012

The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.

artículo científico

Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence

artículo científico publicado en 2014

Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.

artículo científico publicado en 2013

What can we expect from the binding characteristics of azilsartan, a newly available angiotensin II blocker, in hypertension?

artículo científico publicado en 2012

Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.

artículo científico publicado en 2017

Lista de obras de Kengo Azushima

ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in Mice.

Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.

Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.

Adipocyte-Specific Enhancement of Angiotensin II Type 1 Receptor-Associated Protein Ameliorates Diet-Induced Visceral Obesity and Insulin Resistance

Aliskiren induced remarkable hypertriglyceridemia

An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities.

An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model

Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology

Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue

Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line

Angiotensin receptor-binding molecule in leukocytes in association with the systemic and leukocyte inflammatory profile

Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity

Bofu-tsu-shosan, an oriental herbal medicine, exerts a combinatorial favorable metabolic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity

Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes

Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY)

Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease

Day-by-day home-measured blood pressure variability: another important factor in hypertension with diabetic nephropathy?

Deletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension

Dual inhibitory action on aldosterone by combined angiotensin receptor antagonism and neprilysin inhibition

Early Enhanced Leucine-Rich -2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice

Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases.

Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension

Effects of Ang II receptor blocker irbesartan on adipose tissue function in mice with metabolic disorders

Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice

Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia

Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice

Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.

Effects of the Angiotensin receptor blocker olmesartan on adipocyte hypertrophy and function in mice with metabolic disorders.

Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease ⬇️

Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension

Enhancement of intrarenal plasma membrane calcium pump isoform 1 expression in chronic angiotensin II-infused mice

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice

Fetal programming by high-sucrose diet during pregnancy affects the vascular angiotensin II receptor-PKC-L-type Ca(2+) channels (Cav1.2) axis to enhance pressor responses

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabe

Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy

Involvement of Runx3 in the basal transcriptional activation of the mouse angiotensin II type 1 receptor-associated protein gene.

L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.

Mass clinical survey as a possible population strategy for the better control of hypertension in Japan

Modelling diabetic nephropathy in mice.

Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis

Possible impact of electronegative LDL on atherosclerosis in type 2 diabetes

Possible interesting link between Janus kinase 2 mutation and renovascular hypertension.

Possible therapeutic impact of the iron chelation on renal fibrosis

Potential beneficial impact of angiotensin receptor blockers on arterial stiffness in hypertension.

Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors

Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease

Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation

Rituximab treatment for adult purpura nephritis with nephrotic syndrome.

The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.

Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence

Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.

What can we expect from the binding characteristics of azilsartan, a newly available angiotensin II blocker, in hypertension?

Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.